ConductScience.org, home

Paper30144583

Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy.

Yegya-Raman N and 8 others. Pract Radiat Oncol, 2019. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy. Papers, record 30144583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30144583

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy.
PubMed
Journal
Pract Radiat Oncol
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.47
iCite
Revised in PubMed
2020-01-03
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yegya-Raman NNikhil
2Reyhan MMeral
3Kim SSinae
4Deek MPMatthew P
5Yue NNing
6Zou WWei
7Malhotra JJyoti
8Aisner JJoseph
9Jabbour SKSalma K

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
ChemoradiotherapyMajor topic
EsophagitisMajor topic
Neoplasm Recurrence, LocalMajor topic
Radiation PneumonitisMajor topic
Radiotherapy Planning, Computer-AssistedMajor topic
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Cone-Beam Computed Tomography
Female
Follow-Up Studies
Four-Dimensional Computed Tomography
Humans
Image Processing, Computer-Assisted
Lung Neoplasms
Male
Margins of Excision
Middle Aged
Positron-Emission Tomography
Prognosis
Radiotherapy Dosage
Radiotherapy, Intensity-Modulated
Retrospective Studies

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30 CA072720NCI NIH HHSUnited StatesP30CA072720PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111072158Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning.Int J Radiat Oncol Biol Phys2000https://conductscience.org/library/papers/11072158PubMed
217570609Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy.Int J Radiat Oncol Biol Phys2007https://conductscience.org/library/papers/17570609PubMed
324035329Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.Int J Radiat Oncol Biol Phys2013https://conductscience.org/library/papers/24035329PubMed
426929893Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?Cureus2016https://conductscience.org/library/papers/26929893PubMed
520356642Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.Radiother Oncol2010https://conductscience.org/library/papers/20356642PubMed
622425920Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma.J Thorac Oncol2012https://conductscience.org/library/papers/22425920PubMed
729174428Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy.Int J Radiat Oncol Biol Phys2018https://conductscience.org/library/papers/29174428PubMed
820643515Effect of image-guidance frequency on geometric accuracy and setup margins in radiotherapy for locally advanced lung cancer.Int J Radiat Oncol Biol Phys2011https://conductscience.org/library/papers/20643515PubMed
925154893Locoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer.Radiat Oncol2014https://conductscience.org/library/papers/25154893PubMed
1021440998Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer.Int J Radiat Oncol Biol Phys2012https://conductscience.org/library/papers/21440998PubMed
1127646942Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.J Clin Oncol2017https://conductscience.org/library/papers/27646942PubMed
1218303441Image-guided radiation therapy for non-small cell lung cancer.J Thorac Oncol2008https://conductscience.org/library/papers/18303441PubMed
1325601342
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Lancet Oncol2015https://conductscience.org/library/papers/25601342PubMed
1415850904Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?Int J Radiat Oncol Biol Phys2005https://conductscience.org/library/papers/15850904PubMed
1529203290Patterns of locoregional failure in locally advanced non-small cell lung cancer treated with definitive conformal radiotherapy: Results from the Gating 2006 trial.Radiother Oncol2018https://conductscience.org/library/papers/29203290PubMed
1618029110Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy.Int J Radiat Oncol Biol Phys2008https://conductscience.org/library/papers/18029110PubMed
1726623072Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy.Mol Clin Oncol2015https://conductscience.org/library/papers/26623072PubMed
1829933876Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology.Semin Radiat Oncol2018https://conductscience.org/library/papers/29933876PubMed
1917984185Involved-field radiation therapy for inoperable non small-cell lung cancer.J Clin Oncol2007https://conductscience.org/library/papers/17984185PubMed
2020351327Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.J Clin Oncol2010https://conductscience.org/library/papers/20351327PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
38270800Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy.Curr Treat Options Oncol2024https://conductscience.org/library/papers/38270800PubMed
38260217Adaptive Lung Radiation Therapy in the Era of Immunotherapy: A Single-Center Retrospective Study.Adv Radiat Oncol2024https://conductscience.org/library/papers/38260217PubMed
38040540Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial.Clin Lung Cancer2024https://conductscience.org/library/papers/38040540PubMed
37781162Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis.EClinicalMedicine2023https://conductscience.org/library/papers/37781162PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30144583

GET https://conductscience.org/api/papers/v1/30144583/authors